Influence of cigarette smoking on the presentation and course of acute myeloid leukemia

被引:43
作者
Chelghoum, Y
Danaïla, C
Belhabri, A
Charrin, C
Le, QH
Michallet, M
Fiere, D
Thomas, X
机构
[1] Hop Edouard Herriot, Serv Hematol Clin, F-69437 Lyon 03, France
[2] Hop Edouard Herriot, Lab Cent Hematol & Cytogenet, F-69437 Lyon, France
关键词
acute myeloid leukemia; prognosis; smoking;
D O I
10.1093/annonc/mdf269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is known that cigarette smoking is associated with an similar to50% increase in leukemia risk. In order to detect a possible influence of cigarette smoking on initial characteristics at the time of presentation and on the course of the disease, we conducted a retrospective study in 643 patients with newly diagnosed acute myeloid leukemia. Patients and methods: The study comprised 339 males and 304 females (median age 59 years, range 18-84 years). Two hundred and ninety-six patients (46%), smoking at least one cigarette per day for 6 months, were considered as smokers, while 347 patients (54%) were non-smokers. Results: Cigarette smoking was significantly related to male gender (P < 0.0001), professional occupancy (P = 0.002), presence of organomegaly (P = 0.01), and lower peripheral blood and bone marrow leukemic cell involvement (P = 0.007 and P = 0.0001, respectively). Leukemia of French-American-British (FAB) M1 subtype was more frequent in non-smokers (P = 0.005). Although not statistically significant, smokers tended to have lower leukocyte counts than non-smokers. No difference was noted in terms of complete remission rates between smokers and non-smokers (67% compared to 64%). However, a higher rate of severe pulmonary infection was observed in smokers during induction chemotherapy (P = 0.02). Cigarette smoking (≥20 pack-years or smoking duration ≥30 years) was significantly associated with shorter disease-free survival (P = 0.03) and overall survival (OS; P = 0.02 and P = 0.004, respectively). Other characteristics associated with poor prognosis included mainly older age, unfavorable karyotype, secondary acute myeloid leukemia (AML) and elevated World Health Organization (WHO) performance status. Cigarette smoking was associated with shorter OS in younger adults, but did not significantly influence survival in patients >60 years old. Cigarette smoking worsened the poor OS in patients with unfavorable karyotype, but did not significantly influence the prognosis of other karyotypic risk groups. In a multivariate analysis, only karyotypic grouping and age remained of prognostic value for the occurrence of disease-free and overall survival. Conclusions: Cigarette smoking has a deleterious effect on survival in AML by shortening complete remission duration and subsequent survival. It was associated with severe infections during aplasia. Leukemogenic compounds favoring complex karyotypic abnormalities could also be involved.
引用
收藏
页码:1621 / 1627
页数:7
相关论文
共 33 条
[1]  
ARCHIMBAUD E, 1989, CANCER-AM CANCER SOC, V63, P2060, DOI 10.1002/1097-0142(19890515)63:10<2060::AID-CNCR2820631031>3.0.CO
[2]  
2-2
[3]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[4]   Smoking and acute myeloid leukemia:: associations with morphology and karyotypic patterns and evaluation of dose-response relations [J].
Björk, J ;
Albin, M ;
Mauritzson, N ;
Strömberg, U ;
Johansson, B ;
Hagmar, L .
LEUKEMIA RESEARCH, 2001, 25 (10) :865-872
[5]   CIGARETTE-SMOKING AND ADULT LEUKEMIA - A METAANALYSIS [J].
BROWNSON, RC ;
NOVOTNY, TE ;
PERRY, MC .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (04) :469-475
[6]   CIGARETTE-SMOKING AND RISK OF ADULT LEUKEMIA [J].
BROWNSON, RC ;
CHANG, JC ;
DAVIS, JR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (09) :938-941
[7]  
CORRE F, 1971, LANCET, V2, P632
[8]   ARABINOSYL CYTOSINE - A USEFUL AGENT IN TREATMENT OF ACUTE LEUKEMIA IN ADULTS [J].
ELLISON, RR ;
HOLLAND, JF ;
WEIL, M ;
JACQUILLAT, C ;
BOIRON, M ;
BERNARD, J ;
SAWITSKY, A ;
ROSNER, F ;
GUSSOFF, B ;
SILVER, RT ;
KARANAS, A ;
CUTTNER, J ;
SPURR, CL ;
HAYES, DM ;
BLOM, J ;
LEONE, LA ;
HAURANI, F ;
KYLE, R ;
HUTCHISON, JL ;
FORCIER, RJ ;
MOON, JH .
BLOOD, 1968, 32 (04) :507-+
[9]  
GARFINKEL L, 1990, CANCER, V65, P2356, DOI 10.1002/1097-0142(19900515)65:10<2356::AID-CNCR2820651033>3.0.CO
[10]  
2-1